Accelerate the implementation of "data governance" and "data strategy" by helping healthcare institutions to optimize their service's offer through the use of data, by supporting the development of data management tools to meet the demand for care in the territories and by integrating actors who have a legitimate economic interest (Pharma, MedTech, Insurance)
Develop uses of health data by being an educator on new tools and new technologies designed for healthcare professionals, patients, and territories
Contribute to making health data a factor of economic competitiveness by bringing to light strong stakeholders able to influence global and European market.
The Healthcare Data Institute is an association constituted in accordance with the French law of 1901 concerning non-profit organizations.
[French / PDF] Statuts
[French / PDF] Réglement intérieur
[English /PDF] Presentation & Membership Conditions
Graduated from a dual training program in engineering and business, Adel Mebarki is one of the co-founders of Kap Code. Currently deputy general manager of this AI specialized start-up, he’s leading the R&D and business activities to improve real world data knowledge for healthcare industrials.
With several years of experience in developing Natural Language Processing units and IoT products, he developed the necessary skills to manage the whole team composed of various backgrounds, such as engineers, pharmacists, data-scientists, or marketing experts.
Co-author of more than 10 scientific publications, he co-invented two e-health patented solutions and was involve in the redaction of two white papers last year. In addition to its current position in Kap Code, Adel is also acting as an independent expert for the Cap Digital competitiveness cluster and the Data Innovation Program of the Healthcare Data Institute. Passionate about its field of expertise, he teaches Innovation Management in several business schools.
Professor, MD, PhD, Dir of the Institute of Global Health at the Univ of Geneva, and co-Dir of Center Virchow Villermé Univ. Sorbonne Paris Cité
Caroline Henry mainly works in media and new technologies law and in health law.
Doctor of Law, she defended her thesis at the University of Paris I Panthéon-Sorbonne in international law and health law.
She is also a graduate of the master II of law, management and administration of audiovisual and new media from the same university and was top of her class.
As a former lecturer at the University of Paris I Panthéon-Sorbonne, she teaches medical liability law at the Institut de droit des Assurances of the University of Paris-Dauphine.
Since November 1, 2021, Christian Deleuze has been Deputy Managing Director for Innovation to the President of Sanofi France, after 10 years at the head of Sanofi Specialty Care France. He has chaired Sanofi Genzyme Polyclonals, a bioproduction site based in Lyon Gerland since 2010.
In May 2021, he became President of Medicen Paris Region, the Ile de France health competitiveness cluster.
Member of the LEEM board and office, he has chaired the Research and Innovation Commission since 2019.
He also chairs the Healthcare Data Institute, was recently re-elected to the Board of France Biotech, and he is VP of MERI.
Doctor, graduated from ESSEC, his professional career is hybrid and entrepreneurial, from SMEs to very large companies, and his commitment to patients and professional associations are powerful and constant drivers of his action.
Sylvain Durrleman is since 2012 a member of the Management Board of the Institute of Public Health of AVIESAN (French National Alliance for Health and Science), as Partnership Advisor. As such, he is fostering the set-up of public-private partnership in the area of public health, and is closely involved in the development of strategies for large national cohorts, including their linkage to administrative databases (SNDS).
Before joining AVIESAN, Dr. Durrleman spent more than 25 years in the pharmaceutical industry, most recently as Vice-President and member of Sanofi R&D Executive Committee.
During his tenure at Sanofi and predecessor companies (Rhône Poulenc Rorer, Aventis, Sanofi-Synthelabo, Sanofi-aventis, etc..,), as Vice-President for International Clinical Development, he has been responsible for many aspects of new drugs development – from “First in Man” to registration – including biostatistics, data-management, and clinical operations in more than 40 countries.
Prior to joining the pharmaceutical Industry, Dr. Durrleman was a Cancer Expert at the US National Cancer Institute (NCI, NIH, Bethesda, USA).
Dr. Durrleman received his medical degree from the Université René Descartes, Necker Medical School, in Paris, France and holds a DEA/PhD in Biomathematics from the Université Paris VII.
Icham is the director of innovation at Enovacom. Guided by usage, we participate in the design of innovative digital solutions for healthcare professionals by relying on the best internal, institutional or academic experts in the healthcare ecosystem. Before joining Orange Healthcare, he was the deputy IT director of the Rouen University Hospital. He graduated with a PhD in medical informatics in the framework of a CIFRE convention at GSK.
Stéphane is Senior Principal at IQVIA France. He is in charge of the development of strategic partnerships and Thought Leadership.
Stéphane held previous positions as Country Principal and Head of Product & Portfolio Stategy Practice and then Marketing Director. He has an extensive experience in strategic analysis and promotion management consulting projects. He has led various projects comprising forecasting and strategy development in the areas of branding and portfolio management for ethical as well as consumer health companies. He also led strategic projects on growth strategies in emerging markets.
As Marketing Director, he developed his expertise in the development of IMS offerings in data and Consulting & Services.
With McKinsey since 1997, Thomas leads McKinsey’s Healthcare Practice in France. He is a member of the leadership team of the European Health Practice.
He has worked for a wide range of healthcare clients across diverse issues, supporting many hospitals across Europe in their efforts to evolve their strategies and improve performance, and helping design many national healthcare policies (incl. on AMC governance, hospital performance, biomedical research, eHealth, healthcare cost containment, Open Data, hospital IT, etc.).